Screener
Nuvation Bio NUVB Contract Liabilities
Discontinued — last reported Q1 '25
Contract Liabilities at other companies
Segments
By product
Other financials
Where this comes from
Reported directly by Nuvation Bio in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.
The source filing: Nuvation Bio’s 10-Q, filed May 7, 2025.
- Filed
- May 7, 2025
- Fiscal quarter
- Q1 FY2025
- Calendar quarter
- Q1 2025
- Accession
- 0000950170-25-065712
| Line item | March 31, 2025 | December 31, 2024 |
|---|---|---|
| Accrued expenses | 23,892 | 32,833 |
| Total current liabilities | 52,772 | 58,244 |
| Warrant liability | 2,804 | 2,053 |
| Contract liabilities, net of current portion | 13,614 | 15,572 |
| Non-current operating lease liabilities | 3,839 | 969 |
| Total liabilities | 73,029 | 76,838 |
| Commitments and contingencies (Note 11) | ||
| Stockholders’ equity |
Item 1. Financial Statements.
FAQ
- What is Nuvation Bio's contract liabilities?
- Nuvation Bio (NUVB) reported contract liabilities of $13.61M in Q1 2025.
- What does contract liabilities mean?
- Revenue collected or billed in advance of performance — deferred revenue under ASC 606 terminology, representing future revenue obligations.
Ask your AI about Nuvation Bio's contract liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude